Disclosure Information2026-07-31 09:30:37 (KST)
No Date Title Submitter
39 2026/07/31 Report on status of specific securities, etc. owned by executives and major shareholders Prestige BioPharma Limited
38 2026/07/09 Report on Shares Change of Largest Shareholders Prestige BioPharma Limited
37 2026/07/09 Report on status of specific securities, etc. owned by executives and major shareholders Prestige BioPharma Limited
36 2026/07/09 Report on significant holdings of stocks, etc. (General) Prestige BioPharma Limited
35 2026/07/01 Report on Shares Change of Largest Shareholders Prestige BioPharma Limited
34 2026/07/01 Report on significant holdings of stocks, etc. (General) Prestige BioPharma Limited
33 2026/07/01 Report on status of specific securities, etc. owned by executives and major shareholders Prestige BioPharma Limited
32 2026/06/15 Other Management Information(Voluntary Disclosure) Prestige BioPharma Limited
31 2026/06/01 Details of Corporate Governance Report Prestige BioPharma Limited
30 2026/05/29 Quarterly Report (2026.03) Prestige BioPharma Limited
29 2026/03/13 [Corrected description]Conclusion of Single Sales Contract or Supply Contract Prestige BioPharma Limited
28 2026/03/03 Semi-annual Report (2025.12) Prestige BioPharma Limited
27 2026/01/29 [Corrected description]Conclusion of Single Sales Contract or Supply Contract Prestige BioPharma Limited
26 2026/01/21 Report on the Appointment, Dismissal or Early Retirement of Independent Directors Prestige BioPharma Limited
25 2026/01/21 Outcome of Extraordinary Shareholders' Meeting Prestige BioPharma Limited